Christopher Ortaleza I is a New York, New York based chiropractor who is specialized as General Chiropractic. Active license number of Christopher Ortaleza I as General Chiropractic is 013557 in New York. Christopher Ortaleza I is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Christopher Ortaleza I speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
General Chiropractic
Credentials:
DC
Gender:
Male
Practice Address:
442 3rd Ave Apt 30, New York, New York, 10016-6048
Phone:
585-729-0342
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1568135846
NPI Enumeration Date:
31 Jul, 2021
NPI Last Update On:
06 Jan, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Christopher Ortaleza I are as mentioned below.
License Number
Specialization
State
Status
013557
Chiropractor
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
442 3rd Ave Apt 30, New York, New York
Zip:
10016-6048
Phone Number:
585-729-0342
Fax Number:
--
Patients can reach Christopher Ortaleza I at 442 3rd Ave Apt 30, New York, New York or can call to book an appointment on 585-729-0342. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.